10/12/2021
EvoEnzyme is proudly announcing the release of the EVOkit: the first screening kit in the market carrying a selected collection of laboratory evolved peroxygenases -UPOs- from different fun gal species.
With a broad activity and selectivity profile, the rapid oxyfunctionalization of complex organic compounds comes true for pharma and chemical processes.
The development of this product was made possible thanks to the grant co-funded by the European Regional Development Fund (ERDF/FEDER) under the 2019 call for the development of young innovative technology-based companies (Start-ups) and high innovation-intensity SMEs, within the framework of the regional strategy for Research and Innovation for Smart Specialisation (RIS3), under the ERDF/FEDER operational programme of the Community of Madrid. CAM RIS3 Line 1. Project No. S-2019/L1-274.